Psychedelinks is a weekly digest of news, business, and culture in the psychedelics industry curated by members of Emerge Law Group’s groundbreaking Psychedelics Industry Group.
Happy New Year! Below are some psychedelics-related articles to kick us off for 2022!
Here Are The Biggest Marijuana, Psychedelics And Drug Policy News Stories Of 2021
From full cannabis legalization in New York to the launch of a modest medical marijuana program in Alabama, cannabis reform continued to spread across the U.S. in 2021 amid the ongoing backdrop of the COVID-19 pandemic and other hot-button political issues. And while federal prohibition remains in p…
2021: A Year in Review for the Psychedelics Business
Our resident Psychedelic Investor looks back at the biggest moments in the growing psychedelics business, and how they may shape 2022.
Decriminalization, Legalization, & Rescheduling Efforts
Psilocybin Services Would Be Legalized In Washington State Under New Bill
A pair of Washington State lawmakers this week introduced legislation that would legalize what the bill calls “supported psilocybin experiences” by adults 21 and older. If enacted, the Psilocybin Wellness and Opportunity Act would allow individuals to consume products containing psilocybin and psilo…
Buffalo Legislator Eyes Medicinal ‘Magic’ Mushrooms
A Buffalo Assemblyman wants to see New York state get into the medicinal mushroom business. Assemblyman Pat Burke, D-Buffalo, recently introduced A.8569 in the Assembly to allow the medical use of psilocybin and create a $2 million fund to help state residents who qualify pay for the mushroom-based…
Oregon Psilocybin Services Act (M109)
Oregon Psilocybin Services set to launch community interest survey
The Oregon Psilocybin Services Section at Oregon Health Authority is conducting a survey to better understand who may be interested in accessing psilocybin services, service center licensure, facilitator licensure, manufacturer licensure, testing lab licensure and training program approval.
Canada Opens New Legal Pathways For Access To Psychedelics Treatment With Psilocybin And MDMA
In a groundbreaking decision, the Canadian government is changing the way patients can access psychedelic therapies with restricted drugs, including MDMA and psilocybin.
Research, Therapy, & Science
Psychedelic Drug From Magic Mushrooms – Psilocybin – Can Be Safely Administered With No Detrimental Effects in Healthy People
New research from the Institute of Psychiatry, Psychology, & Neuroscience (IoPPN) at King’s College London, in partnership with COMPASS Pathways, has established that psilocybin can be safely administered at doses of either 10mg or 25mg to up to six participants simultaneously. The research,
Red Light Holland Psilocybin Truffles, Sold in The Netherlands, Complete Second Evaluation Under a Health Canada Approved cGMP Laboratory
Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTC Pink: TRUFF), an Ontario-based corporation engaged in the production, growth and sale of a premium brand of magic truffles, is pleased to announce that it has received the second report, produced by Shaman Pharma Corp. and CCrest Laboratories Inc. under a Health Canada Controlled Drugs & Substances license.
Startup To Host Psychedelic Trips In The Metaverse
Psychedelics startup Ei.Ventures announced this week that it purchased virtual land in a digital world where clinicians will host virtual psychedelic therapy sessions.
Debunking Myths and Misconceptions of the Psychedelics Industry
As another psychedelic renaissance begins to take flight, it seems that myths and misconceptions rise to meet it.
Psychedelics Will Have a Big Presence at SXSW in 2022 | Psychedelic Spotlight
Tim Ferriss and Roland Griffiths are among the biggest names in the psychedelics movement that are set to appear during the SXSW Conference.
Subscribe to Psychedelinks to receive essential weekly articles on news, business, and culture in the psychedelics industry, delivered straight to your inbox.
Psychedelinks by Emerge Law Group